Investor Toolbox
Listen to Call
Recording not yet available.
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
MRNA Coverage
Event
Moderna, Inc (MRNA) Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026 AACR Annual Meeting
Apr 17, 2026
Event
Moderna, Inc (MRNA) Q1 2026 Earnings Call
Apr 15, 2026
Event
Moderna, Inc (MRNA) Q1 2026 Earnings Announcement
Apr 15, 2026
Transcript
Moderna, Inc (MRNA) Q4 2025 Earnings Call Transcript
Mar 10, 2026
News
Moderna Q4 2025 net loss narrows; revenue drops 30%
Feb 16, 2026
News
Moderna Reports 4Q Revenue Of $678 Million, Projects 2026 Growth
Feb 13, 2026
Transcript
Moderna, Inc (MRNA) Q2 2022 Earnings Call Transcript
Jan 27, 2026
Transcript
Moderna, Inc (MRNA) Q2 2025 Earnings Call Transcript
Jan 22, 2026